Literature DB >> 1070292

Pelvic exenteration for advanced pelvic malignancies.

H H Yu, C H Leong, G B Ong.   

Abstract

Our experience of 76 pelvic exenterations for advanced pelvic malignancies is presented, with emphasis on the results and complications. The overall operative mortality rate of 14% is acceptable, and a five-year survival rate of 20% has been achieved. The procedure has a definite role to play in the management of advanced but otherwise localized pelvic malignancies.

Entities:  

Mesh：

Year:  1976        PMID： 1070292     DOI： 10.1111/j.1445-2197.1976.tb03314.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN： 0004-8682


  4 in total

1.  Preoperative body mass index, 30-day postoperative morbidity, length of stay and quality of life in patients undergoing pelvic exenteration surgery for recurrent and locally-advanced rectal cancer.

Authors:  Jessica Beaton; Sharon Carey; Michael J Solomon; Ker-Kan Tan; Jane Young
Journal:  Ann Coloproctol       Date:  2014-04-25

2.  A hundred patients with vertical rectus abdominis myocutaneous (VRAM) flap for pelvic reconstruction after total pelvic exenteration.

Authors:  R E Horch; W Hohenberger; A Eweida; U Kneser; K Weber; A Arkudas; S Merkel; J Göhl; J P Beier
Journal:  Int J Colorectal Dis       Date:  2014-04-22       Impact factor: 2.571

3.  Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review.

Authors: 
Journal:  Surg Endosc       Date:  2018-07-17       Impact factor: 4.584

Review 4.  Advances in surgical management for locally recurrent rectal cancer: How far have we come?

Authors:  Daniel Jin-Keat Lee; Peter M Sagar; Gaitri Sadadcharam; Kok-Yang Tan
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.